Compare NEO & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEO | BSTZ |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2008 | N/A |
| Metric | NEO | BSTZ |
|---|---|---|
| Price | $15.00 | $24.04 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $23.40 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 197.4K |
| Earning Date | 10-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | N/A |
| Revenue This Year | $11.12 | N/A |
| Revenue Next Year | $9.68 | N/A |
| P/E Ratio | ★ N/A | $33.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.07 | $20.69 |
| 52 Week High | $20.15 | $31.89 |
| Indicator | NEO | BSTZ |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 35.17 |
| Support Level | $13.43 | $22.95 |
| Resistance Level | $15.31 | $31.59 |
| Average True Range (ATR) | 0.80 | 0.95 |
| MACD | -0.20 | -0.09 |
| Stochastic Oscillator | 3.34 | 16.97 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
BlackRock Science and Technology Trust II is a diversified, closed-end management investment company. Its investment objectives are to provide total return and income mainly through long-term capital appreciation. The Trust invests a majority of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement, and use of science and/or technology. Its investment portfolio comprises securities of companies from various industries, such as semiconductors and semiconductor equipment, software, communications equipment, IT services, and entertainment, etc.